| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |